NATIONAL REGIONAL MEDICAL CENTER (SOUTH CHINA) · WORLD #1 NASOPHARYNGEAL CANCER CENTER

Sun Yat-sen University Cancer Center (SYSUCC)

Founded in 1964, Sun Yat-sen University Cancer Center (SYSUCC) is the largest and most comprehensive academic cancer center in South China. Designated as a World Health Organization (WHO) Collaborating Center for Cancer, SYSUCC is globally renowned as the world’s foremost clinical and research center for nasopharyngeal carcinoma (NPC) and primary liver cancer.

Under the academic leadership of Chinese Academy of Sciences Academician Ma Jun and Hospital President Prof. Xu Ruihua, SYSUCC treats the world’s largest cohort of nasopharyngeal cancer patients, achieving unmatched overall survival rates exceeding 90% for early disease and 80%+ for locally advanced stages, setting the international guidelines adopted by the NCCN.

Sun Yat-sen University Cancer Center Guangzhou
Guangzhou Dual-Campus Complex Yuexiu Campus (651 Dongfeng East Rd) & Modern Huangpu Science City Campus, connected by express aeromedical transport.
Est. 1964
South China Anchor
WHO Collaborating Center for Cancer
2,000+
Specialized Beds
Largest cancer hospital in South China
World #1
NPC Survival & Volume
Highest global nasopharyngeal cure rate
NCCN Guide
Global Guidelines
Formulates international cancer protocols

FOUR CLINICAL EXCELLENCE PILLARS

Core Nasopharyngeal & Gastrointestinal Capabilities

World leader in head and neck radiation oncology, hepatic interventional therapy, and gastrointestinal clinical trials.

Nasopharyngeal Cancer Center

Precision intensity-modulated radiotherapy (IMRT) combined with neoadjuvant chemotherapy, preserving salivary and swallowing functions.

✓ Accredited Clinical Excellence Pillar

Liver Cancer & HAIC

Pioneering hepatic arterial infusion chemotherapy (HAIC), targeted TKIs, and PD-1 immunotherapy for advanced HCC.

✓ Accredited Clinical Excellence Pillar

Colorectal Surgery MDT

International leaders in laparoscopic and robotic intersphincteric resection (ISR) achieving permanent colostomy avoidance.

✓ Accredited Clinical Excellence Pillar

Minimally Invasive Thoracic

Robotic and VATS esophagectomies and radical lung cancer segmentectomies with extensive lymph node clearance.

✓ Accredited Clinical Excellence Pillar

WORLD AUTHORITIES IN NASOPHARYNGEAL & DIGESTIVE ONCOLOGY

Academic Faculty & Department Leadership

Steered by members of the Chinese Academy of Sciences and presidents of international oncology societies.

Academician Ma Jun, MD, PhD

Academician Ma Jun, MD, PhD

Executive Vice President of SYSUCC · Member, Chinese Academy of Sciences

World leader in nasopharyngeal carcinoma research and radiotherapy protocol design. Academician Ma’s clinical trials established international standards that lowered NPC recurrence and radiation toxicity globally.

Focus: Nasopharyngeal carcinoma, precision intensity-modulated radiotherapy, clinical trial design, organ preservation.
View Full Academician / Specialist Profile →
Prof. Xu Ruihua, MD, PhD

Prof. Xu Ruihua, MD, PhD

President of SYSUCC · Past President of Chinese Society of Clinical Oncology (CSCO)

Internationally renowned medical oncologist who spearheaded major trials for gastrointestinal malignancies, defining global standards for metastatic colorectal and gastric cancer systemic therapy.

Focus: Colorectal cancer targeted therapy, immunotherapy combinations, novel drug development, CSCO leadership.
Request Case Review with This Specialist →

CASE INTAKE & SPECIALIST TRIAGE

Initiate Your Case Review with SYSUCC / Sun Yat-sen Cancer Center

Submit your contact details, confirmed diagnosis, and main question below. You do not need to upload any medical files at this stage. Our clinical coordinator will contact you directly within 24–48 hours to discuss potential SYSUCC cancer care pathways in China and assist you in gathering the specific medical records needed for expert hospital review.

    PATIENT INQUIRIES

    Frequently Asked Questions About SYSUCC / Sun Yat-sen Cancer Center

    Key clinical, logistical, and technical facts regarding international admissions, surgical evaluations, advanced technology access, and personalized care coordination at SYSUCC / Sun Yat-sen Cancer Center.

    SYSUCC treats over 4,000 new nasopharyngeal carcinoma patients each year—the highest single-institution volume globally. Academician Ma Jun’s clinical trials have defined the international staging and treatment guidelines adopted by NCCN and ESMO.

    Yes. SYSUCC utilizes advanced intensity-modulated radiotherapy (IMRT) with sub-millimeter target contouring, systematically constraining radiation doses to the parotid and submandibular glands to preserve saliva production.

    Hepatic arterial infusion chemotherapy (HAIC) infuses high concentrations of chemotherapy agents directly into the hepatic artery, maximizing local drug exposure to tumors while minimizing systemic side effects, achieving high tumor shrinkage rates.

    A typical course consists of 30 to 33 daily fractions delivered 5 days per week over approximately 6 to 7 weeks, managed primarily on an outpatient basis.

    MODERN CLINICAL INFRASTRUCTURE

    Strategic Multi-Campus Setup & International Transit

    Modern clinical hubs designed for seamless aeromedical transport, multidisciplinary conferences, and dedicated international inpatient care.

    Main Academic Campus

    SYSUCC Yuexiu Campus

    651 Dongfeng East Road, Yuexiu District, Guangzhou

    Primary clinical and surgical complex in central Guangzhou, housing specialty tumor board rooms and inpatient wards.

    Science City Campus

    SYSUCC Huangpu Campus

    100 Kaitai Avenue, Huangpu District, Guangzhou

    Modern research hospital with high-capacity radiation oncology suites and tranquil healing environments.

    Sun Yat-sen University Cancer Center (SYSUCC)